Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia.

Lanvers-Kaminsky C, Niemann A, Eveslage M, Beck J, Köhnke T, Martin S, de Wit M, Spriewald B, Hauspurg H, Hoelzer D, Boos J, Gökbuget N.

Leuk Lymphoma. 2019 Sep 3:1-8. doi: 10.1080/10428194.2019.1658099. [Epub ahead of print]

PMID:
31480965
2.

Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007.

Boekhoff S, Bison B, Eveslage M, Sowithayasakul P, Müller HL.

Pituitary. 2019 Oct;22(5):532-541. doi: 10.1007/s11102-019-00983-7.

PMID:
31440945
3.

The Postopera tive Quality of Life in Children and Adolescents with Craniopharyngioma.

Eveslage M, Calaminus G, Warmuth-Metz M, Kortmann RD, Pohl F, Timmermann B, Schuhmann MU, Flitsch J, Faldum A, Müller HL.

Dtsch Arztebl Int. 2019 May 3;116(18):321-328. doi: 10.3238/arztebl.2019.0321.

4.

Strain and dyssynchrony in fetuses with congenital heart disease compared to normal controls using speckle tracking echocardiography (STE).

Drop MV, Möllers M, Hammer K, Oelmeier de Murcia K, Falkenberg MK, Braun J, Eveslage M, Köster HA, Klockenbusch W, Steinhard J, Schmitz R.

J Perinat Med. 2019 Aug 27;47(6):598-604. doi: 10.1515/jpm-2019-0073.

PMID:
31141490
5.

Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.

Klotz L, Eschborn M, Lindner M, Liebmann M, Herold M, Janoschka C, Torres Garrido B, Schulte-Mecklenbeck A, Gross CC, Breuer J, Hundehege P, Posevitz V, Pignolet B, Nebel G, Glander S, Freise N, Austermann J, Wirth T, Campbell GR, Schneider-Hohendorf T, Eveslage M, Brassat D, Schwab N, Loser K, Roth J, Busch KB, Stoll M, Mahad DJ, Meuth SG, Turner T, Bar-Or A, Wiendl H.

Sci Transl Med. 2019 May 1;11(490). pii: eaao5563. doi: 10.1126/scitranslmed.aao5563.

PMID:
31043571
6.

Eating behaviour and oxytocin in patients with childhood-onset craniopharyngioma and different grades of hypothalamic involvement.

Daubenbüchel AM, Özyurt J, Boekhoff S, Warmuth-Metz M, Eveslage M, Müller HL.

Pediatr Obes. 2019 Sep;14(9):e12527. doi: 10.1111/ijpo.12527. Epub 2019 Apr 23.

PMID:
31013553
7.

Characteristics, risk factors and treatment reality in livedoid vasculopathy - a multicentre analysis.

Weishaupt C, Strölin A, Kahle B, Kreuter A, Schneider SW, Gerss J, Eveslage M, Drabik A, Goerge T.

J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1784-1791. doi: 10.1111/jdv.15639. Epub 2019 May 14.

PMID:
31009111
8.

Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma.

Bogusz A, Boekhoff S, Warmuth-Metz M, Calaminus G, Eveslage M, Müller HL.

Endocr Connect. 2019 May 1;8(5):481-492. doi: 10.1530/EC-19-0074.

9.

Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma.

Traeger L, Ellermann I, Wiethoff H, Ihbe J, Gallitz I, Eveslage M, Moritz R, Herrmann E, Schrader AJ, Steinbicker AU.

BMC Cancer. 2019 Jan 15;19(1):74. doi: 10.1186/s12885-019-5278-0.

10.

Preoperative anemia and extensive transfusion during stay-in-hospital are critical for patient`s mortality: A retrospective multicenter cohort study of oncological patients undergoing radical cystectomy.

Ceanga AI, Ceanga M, Eveslage M, Herrmann E, Fischer D, Haferkamp A, Wittmann M, Müller S, Van Aken H, Steinbicker AU.

Transfus Apher Sci. 2018 Dec;57(6):739-745. doi: 10.1016/j.transci.2018.08.003. Epub 2018 Sep 5.

PMID:
30301602
11.

Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo).

Boekhoff S, Bogusz A, Sterkenburg AS, Eveslage M, Müller HL.

Eur J Endocrinol. 2018 Oct 12;179(5):331-341. doi: 10.1530/EJE-18-0505.

PMID:
30139824
12.

Hepcidin as a potential predictor for preoperative anemia treatment with intravenous iron-A retrospective pilot study.

Wittkamp C, Traeger L, Ellermann I, Eveslage M, Steinbicker AU.

PLoS One. 2018 Aug 8;13(8):e0201153. doi: 10.1371/journal.pone.0201153. eCollection 2018.

13.

Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity.

Liebmann M, Hucke S, Koch K, Eschborn M, Ghelman J, Chasan AI, Glander S, Schädlich M, Kuhlencord M, Daber NM, Eveslage M, Beyer M, Dietrich M, Albrecht P, Stoll M, Busch KB, Wiendl H, Roth J, Kuhlmann T, Klotz L.

Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):E8017-E8026. doi: 10.1073/pnas.1721049115. Epub 2018 Aug 2.

14.

Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study.

Lohmann L, Janoschka C, Schulte-Mecklenbeck A, Klinsing S, Kirstein L, Hanning U, Wirth T, Schneider-Hohendorf T, Schwab N, Gross CC, Eveslage M, Meuth SG, Wiendl H, Klotz L.

Front Immunol. 2018 Jul 9;9:1560. doi: 10.3389/fimmu.2018.01560. eCollection 2018.

15.

Treating Anemia in the Preanesthesia Assessment Clinic: Results of a Retrospective Evaluation.

Ellermann I, Bueckmann A, Eveslage M, Buddendick H, Latal T, Niehoff D, Geissler RG, Hempel G, Kerkhoff A, Berdel WE, Roeder N, Van Aken HK, Zarbock A, Steinbicker AU.

Anesth Analg. 2018 Nov;127(5):1202-1210. doi: 10.1213/ANE.0000000000003583.

PMID:
29944518
16.

Post-Operative Iron Carboxymaltose May Have an Effect on Haemoglobin Levels in Cardiothoracic Surgical Patients on the ICU - an Observational Pilot Study about Anaemia Treatment with Intravenous Iron.

Peters F, Eveslage M, Gallitz I, Wempe C, Meybohm P, Van Aken HK, Steinbicker AU.

Transfus Med Hemother. 2018 Jan;45(1):42-46. doi: 10.1159/000481143. Epub 2018 Jan 10.

17.

Low concordance between surgical and radiological assessment of degree of resection and treatment-related hypothalamic damage: results of KRANIOPHARYNGEOM 2007.

Müller HL, Reichel J, Boekhoff S, Warmuth-Metz M, Eveslage M, Peng J, Flitsch J.

Pituitary. 2018 Aug;21(4):371-378. doi: 10.1007/s11102-018-0883-5.

PMID:
29589225
18.

Tumour endoprosthesis replacement in the proximal tibia after intra-articular knee resection in patients with sarcoma and recurrent giant cell tumour.

Hardes J, Henrichs MP, Gosheger G, Guder W, Nottrott M, Andreou D, Bormann E, Eveslage M, Hauschild G, Streitbürger A.

Int Orthop. 2018 Oct;42(10):2475-2481. doi: 10.1007/s00264-018-3893-z. Epub 2018 Mar 22.

PMID:
29569138
19.

Adrenal gland size in growth restricted fetuses.

Heese S, Hammer K, Möllers M, Köster HA, Falkenberg MK, Eveslage M, Braun J, Oelmeier de Murcia K, Klockenbusch W, Schmitz R.

J Perinat Med. 2018 Oct 25;46(8):900-904. doi: 10.1515/jpm-2017-0339.

PMID:
29543592
20.

Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007.

Heinks K, Boekhoff S, Hoffmann A, Warmuth-Metz M, Eveslage M, Peng J, Calaminus G, Müller HL.

Endocrine. 2018 Feb;59(2):364-372. doi: 10.1007/s12020-017-1489-9. Epub 2017 Dec 11.

PMID:
29230635
21.

Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer.

Rahbar K, Bögeman M, Yordanova A, Eveslage M, Schäfers M, Essler M, Ahmadzadehfar H.

Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):243-246. doi: 10.1007/s00259-017-3877-z. Epub 2017 Nov 13.

PMID:
29134280
22.

PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.

Rahbar K, Boegemann M, Yordanova A, Eveslage M, Schäfers M, Essler M, Ahmadzadehfar H.

Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):12-19. doi: 10.1007/s00259-017-3848-4. Epub 2017 Oct 12.

PMID:
29026946
23.

Assessment of cervical elastography strain pattern and its association with preterm birth.

Oturina V, Hammer K, Möllers M, Braun J, Falkenberg MK, de Murcia KO, Möllmann U, Eveslage M, Fruscalzo A, Klockenbusch W, Schmitz R.

J Perinat Med. 2017 Nov 27;45(8):925-932. doi: 10.1515/jpm-2016-0375.

PMID:
28258974
24.

Short term storage stability at room temperature of two different platelet-rich plasma preparations from equine donors and potential impact on growth factor concentrations.

Hauschild G, Geburek F, Gosheger G, Eveslage M, Serrano D, Streitbürger A, Johannlükens S, Menzel D, Mischke R.

BMC Vet Res. 2017 Jan 5;13(1):7. doi: 10.1186/s12917-016-0920-4.

25.

Oxytocin in survivors of childhood-onset craniopharyngioma.

Daubenbüchel AM, Hoffmann A, Eveslage M, Özyurt J, Lohle K, Reichel J, Thiel CM, Martens H, Geenen V, Müller HL.

Endocrine. 2016 Nov;54(2):524-531. Epub 2016 Sep 1.

26.

German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.

Rahbar K, Ahmadzadehfar H, Kratochwil C, Haberkorn U, Schäfers M, Essler M, Baum RP, Kulkarni HR, Schmidt M, Drzezga A, Bartenstein P, Pfestroff A, Luster M, Lützen U, Marx M, Prasad V, Brenner W, Heinzel A, Mottaghy FM, Ruf J, Meyer PT, Heuschkel M, Eveslage M, Bögemann M, Fendler WP, Krause BJ.

J Nucl Med. 2017 Jan;58(1):85-90. doi: 10.2967/jnumed.116.183194. Epub 2016 Oct 20.

27.

Nuchal Skinfold Thickness: A Novel Parameter for Assessment of Body Composition in Childhood Craniopharyngioma.

Sterkenburg AS, Hoffmann A, Reichel J, Lohle K, Eveslage M, Warmuth-Metz M, Müller HL.

J Clin Endocrinol Metab. 2016 Dec;101(12):4922-4930. Epub 2016 Sep 28.

28.

Changes in Corneal Densitometry in Patients with Fuchs Endothelial Dystrophy after Endothelial Keratoplasty.

Alnawaiseh M, Rosentreter A, Prokosch V, Eveslage M, Eter N, Zumhagen L.

Curr Eye Res. 2017 Feb;42(2):163-167. doi: 10.3109/02713683.2016.1146774. Epub 2016 Jun 3.

PMID:
27260144
29.

Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial.

Ehrhardt S, Guo N, Hinz R, Schoppen S, May J, Reiser M, Schroeder MP, Schmiedel S, Keuchel M, Reisinger EC, Langeheinecke A, de Weerth A, Schuchmann M, Schaberg T, Ligges S, Eveslage M, Hagen RM, Burchard GD, Lohse AW.

Open Forum Infect Dis. 2016 Jan 29;3(1):ofw011. doi: 10.1093/ofid/ofw011. eCollection 2016 Jan.

30.

ALAIN01--Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential.

Ruck T, Afzali AM, Lukat KF, Eveslage M, Gross CC, Pfeuffer S, Bittner S, Klotz L, Melzer N, Wiendl H, Meuth SG.

BMC Neurol. 2016 Mar 10;16:34. doi: 10.1186/s12883-016-0556-9.

31.

Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial.

Weishaupt C, Strölin A, Kahle B, Kreuter A, Schneider SW, Gerss J, Eveslage M, Drabik A, Goerge T.

Lancet Haematol. 2016 Feb;3(2):e72-9. doi: 10.1016/S2352-3026(15)00251-3. Epub 2016 Jan 16.

PMID:
26853646
32.

Corneal Densitometry, Central Corneal Thickness, and Corneal Central-to-Peripheral Thickness Ratio in Patients With Fuchs Endothelial Dystrophy.

Alnawaiseh M, Zumhagen L, Wirths G, Eveslage M, Eter N, Rosentreter A.

Cornea. 2016 Mar;35(3):358-62. doi: 10.1097/ICO.0000000000000711.

PMID:
26655484
33.

Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia.

Müller-Tidow C, Tschanter P, Röllig C, Thiede C, Koschmieder A, Stelljes M, Koschmieder S, Dugas M, Gerss J, Butterfaß-Bahloul T, Wagner R, Eveslage M, Thiem U, Krause SW, Kaiser U, Kunzmann V, Steffen B, Noppeney R, Herr W, Baldus CD, Schmitz N, Götze K, Reichle A, Kaufmann M, Neubauer A, Schäfer-Eckart K, Hänel M, Peceny R, Frickhofen N, Kiehl M, Giagounidis A, Görner M, Repp R, Link H, Kiani A, Naumann R, Brümmendorf TH, Serve H, Ehninger G, Berdel WE, Krug U; Study Alliance Leukemia Group.

Leukemia. 2016 Mar;30(3):555-61. doi: 10.1038/leu.2015.306. Epub 2015 Nov 2.

PMID:
26522083
34.

History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis.

Hoffmann A, Boekhoff S, Gebhardt U, Sterkenburg AS, Daubenbüchel AM, Eveslage M, Müller HL.

Eur J Endocrinol. 2015 Dec;173(6):853-62. doi: 10.1530/EJE-15-0709. Epub 2015 Sep 21.

PMID:
26392473
35.

Accelerated (18 mW/cm²) Corneal Collagen Cross-Linking for Progressive Keratoconus.

Alnawaiseh M, Rosentreter A, Böhm MR, Eveslage M, Eter N, Zumhagen L.

Cornea. 2015 Nov;34(11):1427-31. doi: 10.1097/ICO.0000000000000578.

PMID:
26356752
36.

Changes in Corneal Transparency After Cross-linking for Progressive Keratoconus: Long-term Follow-up.

Alnawaiseh M, Rosentreter A, Eveslage M, Eter N, Zumhagen L.

J Refract Surg. 2015 Sep;31(9):614-8. doi: 10.3928/1081597X-20150820-07.

PMID:
26352567
37.

Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).

Klotz L, Grützke B, Eveslage M, Deppe M, Gross CC, Kirstein L, Posevitz-Fejfar A, Schneider-Hohendorf T, Schwab N, Meuth SG, Wiendl H.

BMC Neurol. 2015 Jun 23;15:96. doi: 10.1186/s12883-015-0354-9.

38.

Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.

Lanvers-Kaminsky C, Sprowl JA, Malath I, Deuster D, Eveslage M, Schlatter E, Mathijssen RH, Boos J, Jürgens H, Am Zehnhoff-Dinnesen AG, Sparreboom A, Ciarimboli G.

Pharmacogenomics. 2015;16(4):323-32. doi: 10.2217/pgs.14.182.

39.

[Modern study designs and analysis methods in clinical research].

Gerß J, Eveslage M, Faldum A, Schmidt R.

Z Rheumatol. 2015 Mar;74(2):106-12. doi: 10.1007/s00393-014-1450-8. German.

PMID:
25805512
40.

Removing fractured endodontic instruments with a modified tube technique using a light-curing composite.

Wefelmeier M, Eveslage M, Bürklein S, Ott K, Kaup M.

J Endod. 2015 May;41(5):733-6. doi: 10.1016/j.joen.2015.01.018. Epub 2015 Mar 5.

PMID:
25747379
41.

The risk of colorectal cancer in patients with ulcerative colitis.

Nowacki TM, Brückner M, Eveslage M, Tepasse P, Pott F, Thoennissen NH, Hengst K, Ross M, Bettenworth D.

Dig Dis Sci. 2015 Feb;60(2):492-501. doi: 10.1007/s10620-014-3373-2. Epub 2014 Oct 4.

PMID:
25280558
42.

The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells.

Kerl K, Ries D, Unland R, Borchert C, Moreno N, Hasselblatt M, Jürgens H, Kool M, Görlich D, Eveslage M, Jung M, Meisterernst M, Frühwald M.

BMC Cancer. 2013 Jun 13;13:286. doi: 10.1186/1471-2407-13-286.

43.

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

Strangfeld A, Eveslage M, Schneider M, Bergerhausen HJ, Klopsch T, Zink A, Listing J.

Ann Rheum Dis. 2011 Nov;70(11):1914-20. doi: 10.1136/ard.2011.151043. Epub 2011 Jul 25.

Supplemental Content

Loading ...
Support Center